BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26063436)

  • 1. Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses.
    Wang J; Chen Z; Bao L; Zhang W; Xue Y; Pang X; Zhang X; Qin C; Jin Q
    J Virol; 2015 Sep; 89(17):9115-8. PubMed ID: 26063436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.
    Stadlbauer D; Amanat F; Strohmeier S; Nachbagauer R; Krammer F
    Emerg Microbes Infect; 2018 Jun; 7(1):110. PubMed ID: 29925896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus.
    Ito M; Yamayoshi S; Murakami K; Saito K; Motojima A; Nakaishi K; Kawaoka Y
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30754701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
    Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
    Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site A from fifth wave H7N9-infected humans.
    Li M; Chen L; Wang Q; Hao M; Zhang X; Liu L; Yu X; Yang C; Xu J; Chen J; Gong R
    Antiviral Res; 2019 Oct; 170():104556. PubMed ID: 31299269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus.
    Yang F; Xiao Y; Lu R; Chen B; Liu F; Wang L; Yao H; Wu N; Wu H
    Emerg Microbes Infect; 2020; 9(1):664-675. PubMed ID: 32193996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection Against H7 Subtype Influenza Virus Infection in Mice by Passive Transfer of Neutralizing Monoclonal Antibody.
    Zhang Z; Liu M; Zheng S
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):360-5. PubMed ID: 26492625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
    Henry Dunand CJ; Leon PE; Huang M; Choi A; Chromikova V; Ho IY; Tan GS; Cruz J; Hirsh A; Zheng NY; Mullarkey CE; Ennis FA; Terajima M; Treanor JJ; Topham DJ; Subbarao K; Palese P; Krammer F; Wilson PC
    Cell Host Microbe; 2016 Jun; 19(6):800-13. PubMed ID: 27281570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.
    Chen C; Liu L; Xiao Y; Cui S; Wang J; Jin Q
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection.
    Tan GS; Leon PE; Albrecht RA; Margine I; Hirsh A; Bahl J; Krammer F
    PLoS Pathog; 2016 Apr; 12(4):e1005578. PubMed ID: 27081859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.
    Gao R; Sreenivasan CC; Sheng Z; Hause BM; Zhou B; Wentworth DE; Clement T; Rausch D; Brunick C; Christopher-Hennings J; Wu H; Bausch CL; Sullivan EJ; Hoppe AD; Huber VC; Wang D; Li F
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head.
    Jia M; Zhao H; Morano NC; Lu H; Lui YM; Du H; Becker JE; Yuen KY; Ho DD; Kwong PD; Shapiro L; To KK; Wu X
    Nat Commun; 2024 May; 15(1):4505. PubMed ID: 38802413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
    Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
    J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
    Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P
    PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates.
    Pan W; Han L; Dong Z; Niu X; Li Z; Bao L; Li C; Luo Q; Yang Z; Li X; Huang J; Feng L; Qin C; Zhong N; Chen L
    Antiviral Res; 2014 Jul; 107():1-5. PubMed ID: 24746458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus.
    Chen Z; Wang J; Bao L; Guo L; Zhang W; Xue Y; Zhou H; Xiao Y; Wang J; Wu F; Deng Y; Qin C; Jin Q
    Nat Commun; 2015 Mar; 6():6714. PubMed ID: 25819694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
    Schmeisser F; Vasudevan A; Verma S; Wang W; Alvarado E; Weiss C; Atukorale V; Meseda C; Weir JP
    PLoS One; 2015; 10(1):e0117108. PubMed ID: 25629172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.
    Huang KA; Rijal P; Jiang H; Wang B; Schimanski L; Dong T; Liu YM; Chang P; Iqbal M; Wang MC; Chen Z; Song R; Huang CC; Yang JH; Qi J; Lin TY; Li A; Powell TJ; Jan JT; Ma C; Gao GF; Shi Y; Townsend AR
    Nat Microbiol; 2019 Feb; 4(2):306-315. PubMed ID: 30478290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin.
    Yu F; Song H; Wu Y; Chang SY; Wang L; Li W; Hong B; Xia S; Wang C; Khurana S; Feng Y; Wang Y; Sun Z; He B; Hou D; Manischewitz J; King LR; Song Y; Min JY; Golding H; Ji X; Lu L; Jiang S; Dimitrov DS; Ying T
    Cell Host Microbe; 2017 Oct; 22(4):471-483.e5. PubMed ID: 28966056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
    Henry Dunand CJ; Leon PE; Kaur K; Tan GS; Zheng NY; Andrews S; Huang M; Qu X; Huang Y; Salgado-Ferrer M; Ho IY; Taylor W; Hai R; Wrammert J; Ahmed R; García-Sastre A; Palese P; Krammer F; Wilson PC
    J Clin Invest; 2015 Mar; 125(3):1255-68. PubMed ID: 25689254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.